Reasons worth exploring behind the hottest luxury

2022-10-23
  • Detail

Reasons worth exploring behind the luxury drug packaging industry

[China Packaging News] now the large and small exquisite packaging has confused the market and confused the eyes of citizens. A few days ago, Mr. Qian, a citizen, bought several boxes of a brand rheumatism cream at a drugstore in Wuchang for 35.9 yuan/box. When I went home and opened it, I found that most of the palm sized medicine box was empty, with only 8 thin pieces of ointment, which were separately sealed with exquisite paper materials. Is this medicine or packaging? Mr. Qian said that in the early years, the rheumatism cream box was small, and it was sealed with the simplest thin plastic material. Although the packaging is exquisite now, it doesn't mean anything to patients. The price of 44 households in the village has doubled

in the past few days, I visited more than 20 pharmacies in the area from south central Wuchang to jiejiekou, and found that many drug packages are large, exquisite and complex. For example, a brand of cold medicine, there are only 10 pills in a box more than ten centimeters long, shaking with a bang; A kind of medicine for the treatment of children's fever. The big box is covered with a small box, and the small box is filled with a small medicine bottle. People over the age of 30 may remember that the drugs purchased in the past were often round bottles covered with corks, and the bottle mouth was sealed with wax. Since the early 1990s, drugs have become more and more packaged. So what is causing this trend

according to the relevant person of Wuhan Mayinglong pharmacy chain Co., Ltd., the luxury packaging of most drugs is the need to ensure the quality and safety of drugs. Insufficient packaging of drugs will affect safety. For example, some drugs can be packaged with aluminum-plastic in the north, but they may become damp in the south, so they need to be packed with another layer. Some drugs are easy to smell and volatilize, so they must be packaged separately; Some glass bottles are fragile and must be wrapped a little thicker

however, some drugs are packed with ulterior motives. According to industry insiders, some pharmaceutical enterprises deliberately make the packaging box larger to increase the display surface on the counter of the drugstore. The United Industrial consumption impact testing machine is divided into manual pendulum impact testing machine, semi-automatic impact testing machine, digital display impact testing machine, microcomputer controlled impact testing machine, non-metallic impact testing machine, etc., or use exquisite packaging to attract consumers. In addition, some consumers believe that the quality of drugs with exquisite packaging is more assured, so some pharmaceutical companies also compete to cater to this psychology

in fact, there are also hidden rules in the industry that promote the luxury of drug packaging: because the material of drug packaging is also one of the cost factors that will be referred to in drug pricing, some pharmaceutical companies have raised prices on the grounds of high packaging costs

excessive packaging lacks supervision. Some enterprises' bidding price is even lower than the material price itself

it was learned from the industry and Commerce and drug administration departments that the relevant regulations have made certain restrictions on the size proportion and position of drug trade names and generic names on the packaging, but there are no strict restrictions on the space, material and other issues of drug packaging. In addition, at present, the relevant specifications on drug packaging have not been issued. Without specific provisions, it is difficult to define whether the drug packaging is excessive. Some insiders suggested that the competent department could consider further clarifying the drug packaging standards, standardizing the drug packaging forms and specifications, and simplifying the luxury packaging with the round axis at the bottom, which plays a certain role in reducing the drug price and reducing the burden on patients

Copyright © 2011 JIN SHI